Article PDF
References
Yasui N, Kajimoto K, Sumiya T, Okuda T, Iwai N : The monocyte chemotactic protein-1 gene may contribute to hypertension in Dahl salt-sensitive rats. Hypertens Res 2007; 30: 185–193.
Manning RD Jr, Meng S, Tian N : Renal and vascular oxidative stress and salt-sensitivity of arterial pressure. Acta Physiol Scand 2003; 179: 243–250.
Meng S, Cason GW, Gannon AW, Racusen LC, Manning RD Jr : Oxidative stress in Dahl salt-sensitive hypertension. Hypertension 2003; 41: 1346–1352.
Manning RD Jr, Tian N, Meng S : Oxidative stress and antioxidant treatment in hypertension and the associated renal damage. Am J Nephrol 2005; 25: 311–317.
Tian N, Thrasher KD, Gundy PD, Hughson MD, Manning RD Jr : Antioxidant treatment prevents renal damage and dysfunction and reduces arterial pressure in salt-sensitive hypertension. Hypertension 2005; 45: 934–939.
Tian N, Rose RA, Jordan S, Dwyer TM, Hughson MD, Manning RD Jr : N-Acetylcysteine improves renal dysfunction, ameliorates kidney damage and decreases blood pressure in salt-sensitive hypertension. J Hypertens 2006; 24: 2263–2270.
Kobori H, Nishiyama A, Abe Y, Navar LG : Enhancement of intrarenal angiotensinogen in Dahl salt-sensitive rats on high salt diet. Hypertension 2003; 41: 592–597.
Zhou MS, Hernandez Schulman I, Pagano PJ, Jaimes EA, Raij L : Reduced NAD(P)H oxidase in low renin hypertension: link among angiotensin II, atherogenesis, and blood pressure. Hypertension 2006; 47: 81–86.
Kobori H, Ozawa Y, Suzaki Y, et al: Young Scholars Award Lecture: intratubular angiotensinogen in hypertension and kidney diseases. Am J Hypertens 2006; 19: 541–550.
Katsuya T, Ishikawa K, Sugimoto K, Rakugi H, Ogihara T : Salt sensitivity of Japanese from the viewpoint of gene polymorphism. Hypertens Res 2003; 26: 521–525.
Szalai C, Duba J, Prohaszka Z, et al: Involvement of polymorphisms in the chemokine system in the susceptibility for coronary artery disease (CAD). Coincidence of elevated Lp(a) and MCP-1 −2518 G/G genotype in CAD patients. Atherosclerosis 2001; 158: 233–239.
Larrousse M, Bragulat E, Segarra M, Sierra C, Coca A, de La Sierra A : Increased levels of atherosclerosis markers in salt-sensitive hypertension. Am J Hypertens 2006; 19: 87–93.
Chen XL, Tummala PE, Olbrych MT, Alexander RW, Medford RM : Angiotensin II induces monocyte chemoattractant protein-1 gene expression in rat vascular smooth muscle cells. Circ Res 1998; 83: 952–959.
Tian N, Gu JW, Braddy SJ, Rose RA, Hughson MD, Manning RD Jr : Immune suppression prevents renal damage and dysfunction and reduces arterial pressure in salt-sensitive hypertension. Am J Physiol Heart Circ Physiol 2006 ( PMID 17040973).
Nakagawa T, Kang DH, Ohashi R, et al: Tubulointerstitial disease: role of ischemia and microvascular disease. Curr Opin Nephrol Hypertens 2003; 12: 233–241.
Julius S, Nesbitt SD, Egan BM, et al: Feasibility of treating prehypertension with an angiotensin-receptor blocker. N Engl J Med 2006; 354: 1685–1697.
Aljada A, Ghanim H, Saadeh R, Dandona P : Insulin inhibits NFkappaB and MCP-1 expression in human aortic endothelial cells. J Clin Endocrinol Metab 2001; 86: 450–453.
Lalioti MD, Zhang J, Volkman HM, et al: Wnk4 controls blood pressure and potassium homeostasis via regulation of mass and activity of the distal convoluted tubule. Nat Genet 2006; 38: 1124–1132.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Katsuya, T., Rakugi, H. & Ogihara, T. Inflammation and Salt Sensitivity in the Early State of Hypertension. Hypertens Res 30, 105–107 (2007). https://doi.org/10.1291/hypres.30.105
Received:
Issue date:
DOI: https://doi.org/10.1291/hypres.30.105
Keywords
This article is cited by
-
The therapeutic potential of BRD4 in cardiovascular disease
Hypertension Research (2020)
